Health

Pfizer/BioNTech jab safe for children aged five to 11


Dr Ugur Sahin, CEO and co-founder of BioNTech, said: “The safety profile and immunogenicity data in children aged five to 11 years vaccinated at a lower dose are consistent with those we have observed with our vaccine in other older populations at a higher dose.



READ SOURCE

Leave a Reply

This website uses cookies. By continuing to use this site, you accept our use of cookies.